These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7866265)

  • 1. Dual rod pathways in complete achromatopsia.
    Rüther K; Sharpe LT; Zrenner E
    Ger J Ophthalmol; 1994 Nov; 3(6):433-9. PubMed ID: 7866265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that influence the increase in the electroretinogram 30-Hz flicker amplitude during light adaptation.
    Raether K; Zrenner E
    Ger J Ophthalmol; 1996 Sep; 5(5):285-8. PubMed ID: 8911951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNGB3 mutations cause severe rod dysfunction.
    Maguire J; McKibbin M; Khan K; Kohl S; Ali M; McKeefry D
    Ophthalmic Genet; 2018; 39(1):108-114. PubMed ID: 28929832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal response properties of the primary and secondary rod-signaling pathways in normal and Gnat2 mutant mice.
    Nusinowitz S; Ridder WH; Ramirez J
    Exp Eye Res; 2007 Jun; 84(6):1104-14. PubMed ID: 17408617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow and fast rod ERG pathways in patients with X-linked complete stationary night blindness carrying mutations in the NYX gene.
    Scholl HP; Langrová H; Pusch CM; Wissinger B; Zrenner E; Apfelstedt-Sylla E
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2728-36. PubMed ID: 11581222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative relationship of the scotopic and photopic ERG to photoreceptor cell loss in light damaged rats.
    Sugawara T; Sieving PA; Bush RA
    Exp Eye Res; 2000 May; 70(5):693-705. PubMed ID: 10870528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extended 15 Hz ERG protocol (2): data of normal subjects and patients with achromatopsia, CSNB1, and CSNB2.
    Bijveld MM; Riemslag FC; Kappers AM; Hoeben FP; van Genderen MM
    Doc Ophthalmol; 2011 Dec; 123(3):161-72. PubMed ID: 21947599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of scotopic sensitivity.
    Fulton AB; Hansen RM
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1588-96. PubMed ID: 10798680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rod and rod-driven function in achromatopsia and blue cone monochromatism.
    Moskowitz A; Hansen RM; Akula JD; Eklund SE; Fulton AB
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):950-8. PubMed ID: 18824728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dark-adapted rod suppression of cone flicker detection: Evaluation of receptoral and postreceptoral interactions.
    Cao D; Zele AJ; Pokorny J
    Vis Neurosci; 2006; 23(3-4):531-7. PubMed ID: 16961991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for photoreceptor changes in patients with diabetic retinopathy.
    Holopigian K; Greenstein VC; Seiple W; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2355-65. PubMed ID: 9344359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of rod and cone pathways to the dark-adapted electroretinogram (ERG) b-wave following retinal degeneration in RCS rats.
    Pinilla I; Lund RD; Sauvé Y
    Vision Res; 2004; 44(21):2467-74. PubMed ID: 15358082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The visual evoked potential in the mouse--origins and response characteristics.
    Ridder WH; Nusinowitz S
    Vision Res; 2006 Mar; 46(6-7):902-13. PubMed ID: 16242750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram.
    Zeitz C; van Genderen M; Neidhardt J; Luhmann UF; Hoeben F; Forster U; Wycisk K; Mátyás G; Hoyng CB; Riemslag F; Meire F; Cremers FP; Berger W
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4328-35. PubMed ID: 16249515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function.
    Zein WM; Jeffrey BG; Wiley HE; Turriff AE; Tumminia SJ; Tao W; Bush RA; Marangoni D; Wen R; Wei LL; Sieving PA
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6301-8. PubMed ID: 25205868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of color vision abnormality and reduced amplitude of the 30 Hz flicker dark-adapted electroretinographic (ERG).
    Appleton B; Osepchuk J; Cohen J
    Retina; 1995; 15(2):170-2. PubMed ID: 7624609
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram.
    Ben Salah S; Kamei S; Sénéćhal A; Lopez S; Bazalgette C; Bazalgette C; Eliaou CM; Zanlonghi X; Hamel CP
    Am J Ophthalmol; 2008 Jun; 145(6):1099-106. PubMed ID: 18400204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of focal rod electroretinograms from the dark-adapted human eye.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):930-4. PubMed ID: 8603878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo studies of signaling in rod pathways of the mouse using the electroretinogram.
    Robson JG; Maeda H; Saszik SM; Frishman LJ
    Vision Res; 2004 Dec; 44(28):3253-68. PubMed ID: 15535993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.